• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Biophysical characterization of E. coli TolC interaction with the known blocker hexaamminecobalt
 
  • Details
  • Full
Options
2017
Journal Article
Title

Biophysical characterization of E. coli TolC interaction with the known blocker hexaamminecobalt

Abstract
Background The tripartite efflux pump AcrAB-TolC in E. coli is involved in drug resistance by transporting antibiotics out of the cell. The outer membrane protein TolC can be blocked by various cations, including hexaamminecobalt, thereby TolC represents a potential target for reducing antimicrobial resistance as its blockage may improve efficacy of antibiotics. Methods We utilized single channel electrophysiology measurements for studying TolC conductance in the absence and presence of the known TolC blocker hexaamminecobalt. Association and dissociation constants of hexaamminecobalt were determined using surface plasmon resonance measurements. Minimum inhibitory concentration (MIC) assays in the absence and presence of antibiotics were carried out for investigating the antibacterial effect of hexaamminecobalt and its potential to reduce MICs. Results TolC gating in the absence of any ligand is voltage dependent and asymmetric at high applied voltages. Hexaamminecobalt binds to TolC with high affinity and kinetic data revealed fast association and dissociation rates. Despite potent binding to TolC, hexaamminecobalt does not possess an intrinsic antimicrobial activity against E. coli nor does it reduce MIC values of antibiotics erythromycin and fusidic acid. Conclusions TolC opening can be effectively blocked by small molecules. More potent channel blockers are needed in order to investigate the eligibility of TolC as drug target. General significance TolC, a potentially interesting pharmaceutical target can be addressed by small molecules, blocking the channel. Biophysical characterization of the binding processes will support future identification and optimisation of more potent TolC blockers in order to validate TolC as a pharmaceutical target.
Author(s)
Gilardi, A.
Bhamidimarri, S.P.
Brönstrup, M.
Bilitewski, U.
Marreddy, R.K.R.
Pos, K.M.
Benier, L.
Gribbon, P.
Winterhalter, M.
Windshügel, B.
Journal
Biochimica et biophysica acta. General subjects  
DOI
10.1016/j.bbagen.2017.07.014
Language
English
Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024